Engineered NK92 cell-derived exosomes inhibit ovarian cancer progression by degrading GPRC5A

Chaohua Si(Chinese Academy of Medical Sciences & Peking Union Medical College), Xu Ma(National Health and Family Planning Commission), Jianen Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yunwen Wang(Genetic Resources Center), Yuxuan Fan(Genetic Resources Center), Yihan Wang(University of Maryland, Baltimore), Yuanyuan Li(Binzhou University), Yuqi Chen, Yanan Tian(Genetic Resources Center)
Frontiers in Immunology
November 11, 2025
Cited by 6


Related Papers